PKM and urinary bladder cancer: To further clarify the mechanism behind, in our next study, the PKM2 activity of all shikonin-treated bladder cancer cells will be measured, together with the expression level of PKM1, which might be upregulated during PKM2 inhibition and reduce cancer cell proliferation.